by admin | Oct 29, 2022 | wpApi
Our Solution Establishment of a therapy that promotes endogenous cardiac myocyte regeneration in the ischemic heart to reduce infarct size offers a potential treatment of IHD, reducing morbidity and mortality. Inhibition of a specific combination of four mircroRNAs...
by admin | Oct 28, 2022 | wpApi
Jaan Biotherapeutics, LLC is a private company that is developing novel therapies to activate the cardiac regeneration process in diseased hearts using proprietary technology. The technology manipulates microRNAs to activate an endogenous cardiac muscle regeneration...
by admin | Oct 27, 2022 | wpApi
A new class of therapies to treat cardiovascular diseases
by admin | Oct 27, 2022 | wpApi
This is a test
by admin | Oct 26, 2020 | Publications
...
